Distributive sharing among HIV-HCV co-infected injecting drug users: The preventive role of trust in one's physician

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 24, Issue 2, 2012, Pages 232-238

  Jauffret Roustide, Marie ^a,b   Cohen, Julien ^c,d,e   Poisot Martin, Isabelle ^f   Spire, Bruno ^c,d,e   Gossop, Michael ^g   Carrieri, M Patrizia ^c,d  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b EHESS Sciences   (France)

^c AIX MARSEILLE UNIV   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^f HÔPITAL SAINTE MARGUERITE   (France)

^g KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

co infection HIV HCV; drug users; high risk behaviors; trust in physician

Indexed keywords

ADULT; ARTICLE; COCAINE DEPENDENCE; DOCTOR PATIENT RELATION; DRUG ABUSE; FEMALE; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEEDLE; PATIENT ATTITUDE; PHYSICIAN; PRIORITY JOURNAL; SELF REPORT; SYRINGE; TRUST;

ADULT; COHORT STUDIES; COINFECTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; NEEDLE SHARING; PHYSICIAN-PATIENT RELATIONS; RISK FACTORS; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; TRUST;

EID: 84856943190     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2011.596515     Document Type: Article

References (40)

1. Alter, M.J. 2006. Epidemiology of viral hepatitis and HIV co-infection. Journal of Hepatology, 44 (Suppl. 1): S6-9.
2. Bouhnik, A.D., Carrieri, M.P., Rey, D., Spire, B., Gastaut, J.A., Gallais, H., et al. 2004. Drug injection cessation among HIV-infected injecting drug users. Addictive Behaviour 29 6, 1189-1197. (Pubitemid 38962347)
3. Carrieri, M.P., Moatti, J.P., Vlahov, D., Obadia, Y., Reynaud-Maurupt, C., and, Chesney, M. 1999. Access to antiretroviral treatment among French HIV infected injection drug users: The influence of continued drug use. MANIF 2000 Study Group. Journal of Epidemiology and Community Health, 53 (1): 4-8. (Pubitemid 29012343)
4. Cazein, F., Pillonel, J., Le Strat, Y., Lot, F., Pinget, R., David, D. 2008. Surveillance de l'infection VIH-sida en France, 2007. Bulletin Epidemiologique Hebdomadaire, 45-46: 434-442.
5. Compton, W.M., Lamb, R.J., and, Fletcher, B.W. 1995. Results of the NIDA treatment demonstration grants cocaine workgroup: Characteristics of cocaine users and HIV risk behaviors. Drug and Alcohol Dependence, 37 (1): 1-6.
6. Currie, S.L., Ryan, J.C., Tracy, D., Wright, T.L., George, S., McQuaid, R., et al. 2008. A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus. Drug and Alcohol Dependence 93 1-2, 148-154. (Pubitemid 350236602)
7. Darke, S. 1998. Self-report among injecting drug users: A review. Drug and Alcohol Dependence 51 3, 253-263; discussion 267-258.
8. Deren, S., Kang, S.Y., Colon, H.M., Andia, J.F., and, Robles, R.R. 2004. HIV incidence among high-risk Puerto Rican drug users: A comparison of East Harlem, New York, and Bayamon, Puerto Rico. Journal of Acquired Immune Deficiency Syndromes, 36 (5): 1067-1074. (Pubitemid 38989373)
9. Des Jarlais, D.C., Perlis, T., Arasteh, K., Torian, L.V., Hagan, H., Beatrice, S., et al. 2005. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS 19 Suppl 3, S20-25.
10. Emmanuelli, J., and, Desenclos, J.C. 2005. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Addiction, 100 (11): 1690-1700. (Pubitemid 41626829)
11. Fuhrer, R., and, Rouillon, F. 1989. La version franaise de l'échelle CES-D. Description and translation of the autoevaluation scale (in French). Psychiatrie et Psychobiologie, 4: 163-166. (Pubitemid 19210689)
12. George, M., &, Martin, E. 1992. GP's attitudes towards drug users. British Journal of General Practice 42 360,. 302.
13. Guadagnino, V., Zimatore, G., Izzi, A., Caroleo, B., Rocca, A., Montesano, F. 1995. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy. Journal of Clinical and Laboratory Immunology, 47 (1): 1-9.
14. Hagan, H., Thiede, H., Weiss, N.S., Hopkins, S.G., Duchin, J.S., and, Alexander, E.R. 2001. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91 (1): 42-46. (Pubitemid 32049265)
15. Hope, V., Kimber, J., Vickerman, P., Hickman, M., and, Ncube, F. 2008. Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England. BMC Infectious Diseases, 8: 120
16. Hope, V.D., Marongiu, A., Parry, J.V., &, Ncube, F. 2010. The extent of injection site infection in injecting drug users: Findings from a national surveillance study. Epidemiology and Infection 1-9.
17. Ireland, R., and, McLeod, I. 1995. Drug users' views on general practitioners. BMJ, 310 (6991): 1407-1408.
18. Jauffret-Roustide, M., Emmanuelli, J., Quaglia, M., Barin, F., Arduin, P., Laporte, A. et al. 2006. Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: Recent French data-the ANRS-Coquelicot Study. Substance Use and Misuse 41 10-12, 1603-1621. (Pubitemid 44470232)
19. Jauffret-Roustide, M., Le Strat, Y., Couturier, E., Thierry, D., Rondy, M., Quaglia, M., et al. 2009. A national cross-sectional study among drug-users in France: Epidemiology of HCV and highlight on practical and statistical aspects of the design. BMC Infectious Diseases 9, 113.
20. Latkin, C.A., and, Vlahov, D. 1998. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction, 93 (8): 1191-1197. (Pubitemid 28370592)
21. Martin, D.J., Garske, J.P., and, Davis, M.K. 2000. Relation of the therapeutic alliance with outcome and other variables: A meta-analytic review. Journal of Consulting and Clinical Psychology, 68 (3): 438-450.
22. McCoy, C.B., Metsch, L.R., Chitwood, D.D., Shapshak, P., and, Comerford, S.T. 1998. Parenteral transmission of HIV among injection drug users: Assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18 (Suppl 1): S25-29.
23. McGillion, J., Wanigaratne, S., Feinmann, C., Godden, T., and, Byrne, A. 2000. GPs attitudes towards the treatment of drug misusers. British Journal of General Practice, 50 (454): 385-386. (Pubitemid 30245618)
24. Meier, P.S., Donmall, M.C., Barrowclough, C., McElduff, P., and, Heller, R.F. 2005. Predicting the early therapeutic alliance in the treatment of drug misuse. Addiction, 100 (4): 500-511. (Pubitemid 40529843)
25. Meier, P.S., Donmall, M.C., McElduff, P., Barrowclough, C., and, Heller, R.F. 2006. The role of the early therapeutic alliance in predicting drug treatment dropout. Drug and Alcohol Dependence, 83 (1): 57-64.
26. Mertz, D., Viktorin, N., Wolbers, M., Fluckiger, U., &, Battegay, M. 2009. Impact of HIV status on outcome of infectious complications in intravenous drug users. Journal of Acquired Immune Deficiency Syndrome 51 4, 506-507; author reply 507-508.
27. Metsch, L.R., Pereyra, M., Purcell, D.W., Latkin, C.A., Malow, R., Gomez, C.A., et al. 2007. Correlates of lending needles/syringes among HIV-seropositive injection drug users. Journal of Acquired Immune Deficiency Syndrome 46 Suppl 2, S72-79.
28. Nord, D. 1997. Threats to identity in survivors of multiple AIDS-related losses. American Journal of Psychotherapy, 51 (3): 387-402. (Pubitemid 27418483)
29. Patrick, D.M., Tyndall, M.W., Cornelisse, P.G., Li, K., Sherlock, C.H., Rekart, M.L. 2001. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ, 165 (7): 889-895. (Pubitemid 34028226)
30. Peretti-Watel, P., Spire, B., Lert, F., &, Obadia, Y. 2005. Seropositive people infected through intravenous drug use: A persistent vulnerability. Review Pratice 55 19, 2093-2100. (Pubitemid 43010180)
31. Radloff, L. 1977. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 3: 385-491.
32. Reynaud-Maurupt, C., Carrieri, M.P., Gastaud, J.A., Pradier, C., Obadia, Y., and, Moatti, J.P. 2000. Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs. The MANIF 2000 Study Group. AIDS Care, 12 (4): 461-470. (Pubitemid 30618191)
33. Rhodes, T. 2009. Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy, 20 (3): 193-201.
34. Rhodes, T., Watts, L., Davies, S., Martin, A., Smith, J., Clark, D., et al. 2007. Risk, shame and the public injector: A qualitative study of drug injecting in South Wales. Social Science and Medicine 65 3, 572-585. (Pubitemid 47017521)
35. Roux, P., Cohen, J., Lascoux-Combe, C., Sogni, P., Winnock, M., Salmon-Ceron, D., et al. 2011. Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: The role of the physician. Drug and Alcohol Dependence 116 1-3, 228-232.
36. Santibanez, S.S., Garfein, R.S., Swartzendruber, A., Kerndt, P.R., Morse, E., Ompad, D., et al. 2005. Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. Drug and Alcohol Dependence 77 3, 227-233. (Pubitemid 40283524)
37. Smit, C., Lindenburg, K., Geskus, R.B., Brinkman, K., Coutinho, R.A., and, Prins, M. 2006. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour. Addiction, 101 (3): 433-440. (Pubitemid 43344826)
38. Spire, B., Lucas, G.M., and, Carrieri, M.P. 2007. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). International Journal of Drug Policy, 18 (4): 262-270. (Pubitemid 47126278)
39. van de Laar, M.J., and, Likatavicius, G. 2009. HIV and AIDS in the European Union, 2008. Euro Surveillance, 14 (47)
40. Van Den Berg, C., Smit, C., Van Brussel, G., Coutinho, R., and, Prins, M. 2007. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction, 102 (9): 1454-1462. (Pubitemid 47246988)